For example, the possibility exists for the augmentation of MMR and the HR system in cancer cells with MGMT in an inactive state, such as in GBM with a methylated MGMT promoter, which has potential to interfere with TMZ cytotoxicity. This evidence concerns the gene MGMT and glioblastoma.